Study details
Enrolling now
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
University of Michigan Rogel Cancer Center
NCT IDNCT07443943ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
All ages
Locations
1 site in MI
What this study is about
This Phase 2 study is testing Potato in people with anatomic stage 0 breast cancer ajcc v8.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
Cell-mediated Immunity
Endpoints
Secondary: Incidence of adverse events, Proportion of patients who discontinue initially prescribed aromatase inhibitor medication due to toxicity
Body systems
Oncology